The global market for Nuclear Medicine was estimated to be worth US$ 6189.2 million in 2023 and is forecast to a readjusted size of US$ 10260 million by 2030 with a CAGR of 7.4% during the forecast period 2024-2030

Nuclear Medicine - Market

Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.

Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.

The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.

Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nuclear Medicine by region & country, by Type, and by Application.

The Nuclear Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.

Market Segmentation

Scope of Nuclear Medicine - Market Report

Report Metric	Details
Report Name	Nuclear Medicine - Market
Forecasted market size in 2030	US$ 10260 million
CAGR	7.4%
Forecasted years	2024 - 2030
Segment by Type:	Tc-99 I-123/131 In-111 Xe-133 Th-201 Ga-67 Others
Segment by Application	Diagnostic Therapeutic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma, Eli Lilly, SIEMENS, China Isotope & Radiation, Dongcheng
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nuclear Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Nuclear Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Nuclear Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Nuclear Medicine - Market size in 2030?

Ans: The Nuclear Medicine - Market size in 2030 will be US$ 10260 million.

What is the Nuclear Medicine - Market share by application?

Ans: The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.

Who are the main players in the Nuclear Medicine - Market report?

Ans: The main players in the Nuclear Medicine - Market are GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma, Eli Lilly, SIEMENS, China Isotope & Radiation, Dongcheng

What are the Application segmentation covered in the Nuclear Medicine - Market report?

Ans: The Applications covered in the Nuclear Medicine - Market report are Diagnostic, Therapeutic

What are the Type segmentation covered in the Nuclear Medicine - Market report?

Ans: The Types covered in the Nuclear Medicine - Market report are Tc-99, I-123/131, In-111, Xe-133, Th-201, Ga-67, Others

1 Market Overview

1.1 Nuclear Medicine Product Introduction

1.2 Global Nuclear Medicine Market Size Forecast

1.3 Nuclear Medicine Market Trends & Drivers

1.3.1 Nuclear Medicine Industry Trends

1.3.2 Nuclear Medicine Market Drivers & Opportunity

1.3.3 Nuclear Medicine Market Challenges

1.3.4 Nuclear Medicine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Nuclear Medicine Players Revenue Ranking (2023)

2.2 Global Nuclear Medicine Revenue by Company (2019-2024)

2.3 Key Companies Nuclear Medicine Manufacturing Base Distribution and Headquarters

2.4 Key Companies Nuclear Medicine Product Offered

2.5 Key Companies Time to Begin Mass Production of Nuclear Medicine

2.6 Nuclear Medicine Market Competitive Analysis

2.6.1 Nuclear Medicine Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Nuclear Medicine Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Tc-99

3.1.2 I-123/131

3.1.3 In-111

3.1.4 Xe-133

3.1.5 Th-201

3.1.6 Ga-67

3.1.7 Others

3.2 Global Nuclear Medicine Sales Value by Type

3.2.1 Global Nuclear Medicine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Nuclear Medicine Sales Value, by Type (2019-2030)

3.2.3 Global Nuclear Medicine Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Diagnostic

4.1.2 Therapeutic

4.2 Global Nuclear Medicine Sales Value by Application

4.2.1 Global Nuclear Medicine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Nuclear Medicine Sales Value, by Application (2019-2030)

4.2.3 Global Nuclear Medicine Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Nuclear Medicine Sales Value by Region

5.1.1 Global Nuclear Medicine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Nuclear Medicine Sales Value by Region (2019-2024)

5.1.3 Global Nuclear Medicine Sales Value by Region (2025-2030)

5.1.4 Global Nuclear Medicine Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Nuclear Medicine Sales Value, 2019-2030

5.2.2 North America Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Nuclear Medicine Sales Value, 2019-2030

5.3.2 Europe Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Nuclear Medicine Sales Value, 2019-2030

5.4.2 Asia Pacific Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Nuclear Medicine Sales Value, 2019-2030

5.5.2 South America Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Nuclear Medicine Sales Value, 2019-2030

5.6.2 Middle East & Africa Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Nuclear Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Nuclear Medicine Sales Value

6.3 United States

6.3.1 United States Nuclear Medicine Sales Value, 2019-2030

6.3.2 United States Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Nuclear Medicine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Nuclear Medicine Sales Value, 2019-2030

6.4.2 Europe Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Nuclear Medicine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Nuclear Medicine Sales Value, 2019-2030

6.5.2 China Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Nuclear Medicine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Nuclear Medicine Sales Value, 2019-2030

6.6.2 Japan Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Nuclear Medicine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Nuclear Medicine Sales Value, 2019-2030

6.7.2 South Korea Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Nuclear Medicine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Nuclear Medicine Sales Value, 2019-2030

6.8.2 Southeast Asia Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Nuclear Medicine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Nuclear Medicine Sales Value, 2019-2030

6.9.2 India Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Nuclear Medicine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GE Healthcare

7.1.1 GE Healthcare Profile

7.1.2 GE Healthcare Main Business

7.1.3 GE Healthcare Nuclear Medicine Products, Services and Solutions

7.1.4 GE Healthcare Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.1.5 GE Healthcare Recent Developments

7.2 Bracco Imaging

7.2.1 Bracco Imaging Profile

7.2.2 Bracco Imaging Main Business

7.2.3 Bracco Imaging Nuclear Medicine Products, Services and Solutions

7.2.4 Bracco Imaging Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.2.5 Bracco Imaging Recent Developments

7.3 Mallinckrodt

7.3.1 Mallinckrodt Profile

7.3.2 Mallinckrodt Main Business

7.3.3 Mallinckrodt Nuclear Medicine Products, Services and Solutions

7.3.4 Mallinckrodt Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.3.5 Lantheus Medical Imaging Recent Developments

7.4 Lantheus Medical Imaging

7.4.1 Lantheus Medical Imaging Profile

7.4.2 Lantheus Medical Imaging Main Business

7.4.3 Lantheus Medical Imaging Nuclear Medicine Products, Services and Solutions

7.4.4 Lantheus Medical Imaging Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.4.5 Lantheus Medical Imaging Recent Developments

7.5 Bayer

7.5.1 Bayer Profile

7.5.2 Bayer Main Business

7.5.3 Bayer Nuclear Medicine Products, Services and Solutions

7.5.4 Bayer Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.5.5 Bayer Recent Developments

7.6 Triad Isotopes

7.6.1 Triad Isotopes Profile

7.6.2 Triad Isotopes Main Business

7.6.3 Triad Isotopes Nuclear Medicine Products, Services and Solutions

7.6.4 Triad Isotopes Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.6.5 Triad Isotopes Recent Developments

7.7 Nordion

7.7.1 Nordion Profile

7.7.2 Nordion Main Business

7.7.3 Nordion Nuclear Medicine Products, Services and Solutions

7.7.4 Nordion Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.7.5 Nordion Recent Developments

7.8 Jubilant Pharma

7.8.1 Jubilant Pharma Profile

7.8.2 Jubilant Pharma Main Business

7.8.3 Jubilant Pharma Nuclear Medicine Products, Services and Solutions

7.8.4 Jubilant Pharma Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.8.5 Jubilant Pharma Recent Developments

7.9 Eli Lilly

7.9.1 Eli Lilly Profile

7.9.2 Eli Lilly Main Business

7.9.3 Eli Lilly Nuclear Medicine Products, Services and Solutions

7.9.4 Eli Lilly Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.9.5 Eli Lilly Recent Developments

7.10 SIEMENS

7.10.1 SIEMENS Profile

7.10.2 SIEMENS Main Business

7.10.3 SIEMENS Nuclear Medicine Products, Services and Solutions

7.10.4 SIEMENS Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.10.5 SIEMENS Recent Developments

7.11 China Isotope & Radiation

7.11.1 China Isotope & Radiation Profile

7.11.2 China Isotope & Radiation Main Business

7.11.3 China Isotope & Radiation Nuclear Medicine Products, Services and Solutions

7.11.4 China Isotope & Radiation Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.11.5 China Isotope & Radiation Recent Developments

7.12 Dongcheng

7.12.1 Dongcheng Profile

7.12.2 Dongcheng Main Business

7.12.3 Dongcheng Nuclear Medicine Products, Services and Solutions

7.12.4 Dongcheng Nuclear Medicine Revenue (US$ Million) & (2019-2024)

7.12.5 Dongcheng Recent Developments

8 Industry Chain Analysis

8.1 Nuclear Medicine Industrial Chain

8.2 Nuclear Medicine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Nuclear Medicine Sales Model

8.5.2 Sales Channel

8.5.3 Nuclear Medicine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

GE Healthcare

Bracco Imaging

Mallinckrodt plc

Lantheus Medical Imaging

China Isotope & Radiation

Dongcheng

List of Tables

Table 1. Nuclear Medicine Market Trends

Table 2. Nuclear Medicine Market Drivers & Opportunity

Table 3. Nuclear Medicine Market Challenges

Table 4. Nuclear Medicine Market Restraints

Table 5. Global Nuclear Medicine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Nuclear Medicine Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Nuclear Medicine Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Nuclear Medicine Product Type

Table 9. Key Companies Time to Begin Mass Production of Nuclear Medicine

Table 10. Global Nuclear Medicine Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Nuclear Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Nuclear Medicine Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Nuclear Medicine Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Nuclear Medicine Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Nuclear Medicine Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Nuclear Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Nuclear Medicine Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Nuclear Medicine Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Nuclear Medicine Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Nuclear Medicine Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Nuclear Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Nuclear Medicine Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Nuclear Medicine Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Nuclear Medicine Sales Value by Region (2019-2024) & (%)

Table 27. Global Nuclear Medicine Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Nuclear Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Nuclear Medicine Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Nuclear Medicine Sales Value, (2025-2030) & (US$ Million)

Table 31. GE Healthcare Basic Information List

Table 32. GE Healthcare Description and Business Overview

Table 33. GE Healthcare Nuclear Medicine Products, Services and Solutions

Table 34. Revenue (US$ Million) in Nuclear Medicine Business of GE Healthcare (2019-2024)

Table 35. GE Healthcare Recent Developments

Table 36. Bracco Imaging Basic Information List

Table 37. Bracco Imaging Description and Business Overview

Table 38. Bracco Imaging Nuclear Medicine Products, Services and Solutions

Table 39. Revenue (US$ Million) in Nuclear Medicine Business of Bracco Imaging (2019-2024)

Table 40. Bracco Imaging Recent Developments

Table 41. Mallinckrodt Basic Information List

Table 42. Mallinckrodt Description and Business Overview

Table 43. Mallinckrodt Nuclear Medicine Products, Services and Solutions

Table 44. Revenue (US$ Million) in Nuclear Medicine Business of Mallinckrodt (2019-2024)

Table 45. Mallinckrodt Recent Developments

Table 46. Lantheus Medical Imaging Basic Information List

Table 47. Lantheus Medical Imaging Description and Business Overview

Table 48. Lantheus Medical Imaging Nuclear Medicine Products, Services and Solutions

Table 49. Revenue (US$ Million) in Nuclear Medicine Business of Lantheus Medical Imaging (2019-2024)

Table 50. Lantheus Medical Imaging Recent Developments

Table 51. Bayer Basic Information List

Table 52. Bayer Description and Business Overview

Table 53. Bayer Nuclear Medicine Products, Services and Solutions

Table 54. Revenue (US$ Million) in Nuclear Medicine Business of Bayer (2019-2024)

Table 55. Bayer Recent Developments

Table 56. Triad Isotopes Basic Information List

Table 57. Triad Isotopes Description and Business Overview

Table 58. Triad Isotopes Nuclear Medicine Products, Services and Solutions

Table 59. Revenue (US$ Million) in Nuclear Medicine Business of Triad Isotopes (2019-2024)

Table 60. Triad Isotopes Recent Developments

Table 61. Nordion Basic Information List

Table 62. Nordion Description and Business Overview

Table 63. Nordion Nuclear Medicine Products, Services and Solutions

Table 64. Revenue (US$ Million) in Nuclear Medicine Business of Nordion (2019-2024)

Table 65. Nordion Recent Developments

Table 66. Jubilant Pharma Basic Information List

Table 67. Jubilant Pharma Description and Business Overview

Table 68. Jubilant Pharma Nuclear Medicine Products, Services and Solutions

Table 69. Revenue (US$ Million) in Nuclear Medicine Business of Jubilant Pharma (2019-2024)

Table 70. Jubilant Pharma Recent Developments

Table 71. Eli Lilly Basic Information List

Table 72. Eli Lilly Description and Business Overview

Table 73. Eli Lilly Nuclear Medicine Products, Services and Solutions

Table 74. Revenue (US$ Million) in Nuclear Medicine Business of Eli Lilly (2019-2024)

Table 75. Eli Lilly Recent Developments

Table 76. SIEMENS Basic Information List

Table 77. SIEMENS Description and Business Overview

Table 78. SIEMENS Nuclear Medicine Products, Services and Solutions

Table 79. Revenue (US$ Million) in Nuclear Medicine Business of SIEMENS (2019-2024)

Table 80. SIEMENS Recent Developments

Table 81. China Isotope & Radiation Basic Information List

Table 82. China Isotope & Radiation Description and Business Overview

Table 83. China Isotope & Radiation Nuclear Medicine Products, Services and Solutions

Table 84. Revenue (US$ Million) in Nuclear Medicine Business of China Isotope & Radiation (2019-2024)

Table 85. China Isotope & Radiation Recent Developments

Table 86. Dongcheng Basic Information List

Table 87. Dongcheng Description and Business Overview

Table 88. Dongcheng Nuclear Medicine Products, Services and Solutions

Table 89. Revenue (US$ Million) in Nuclear Medicine Business of Dongcheng (2019-2024)

Table 90. Dongcheng Recent Developments

Table 91. Key Raw Materials Lists

Table 92. Raw Materials Key Suppliers Lists

Table 93. Nuclear Medicine Downstream Customers

Table 94. Nuclear Medicine Distributors List

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

Table 98. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Nuclear Medicine Product Picture

Figure 2. Global Nuclear Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Nuclear Medicine Sales Value (2019-2030) & (US$ Million)

Figure 4. Nuclear Medicine Report Years Considered

Figure 5. Global Nuclear Medicine Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Nuclear Medicine Revenue in 2023

Figure 7. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Tc-99 Picture

Figure 9. I-123/131 Picture

Figure 10. In-111 Picture

Figure 11. Xe-133 Picture

Figure 12. Th-201 Picture

Figure 13. Ga-67 Picture

Figure 14. Others Picture

Figure 15. Global Nuclear Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Nuclear Medicine Sales Value Market Share by Type, 2023 & 2030

Figure 17. Product Picture of Diagnostic

Figure 18. Product Picture of Therapeutic

Figure 19. Global Nuclear Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 20. Global Nuclear Medicine Sales Value Market Share by Application, 2023 & 2030

Figure 21. North America Nuclear Medicine Sales Value (2019-2030) & (US$ Million)

Figure 22. North America Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

Figure 23. Europe Nuclear Medicine Sales Value (2019-2030) & (US$ Million)

Figure 24. Europe Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

Figure 25. Asia Pacific Nuclear Medicine Sales Value (2019-2030) & (US$ Million)

Figure 26. Asia Pacific Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

Figure 27. South America Nuclear Medicine Sales Value (2019-2030) & (US$ Million)

Figure 28. South America Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

Figure 29. Middle East & Africa Nuclear Medicine Sales Value (2019-2030) & (US$ Million)

Figure 30. Middle East & Africa Nuclear Medicine Sales Value by Country (%), 2023 VS 2030

Figure 31. Key Countries/Regions Nuclear Medicine Sales Value (%), (2019-2030)

Figure 32. United States Nuclear Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 33. United States Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

Figure 34. United States Nuclear Medicine Sales Value by Application (%), 2023 VS 2030

Figure 35. Europe Nuclear Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 36. Europe Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

Figure 37. Europe Nuclear Medicine Sales Value by Application (%), 2023 VS 2030

Figure 38. China Nuclear Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 39. China Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

Figure 40. China Nuclear Medicine Sales Value by Application (%), 2023 VS 2030

Figure 41. Japan Nuclear Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 42. Japan Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

Figure 43. Japan Nuclear Medicine Sales Value by Application (%), 2023 VS 2030

Figure 44. South Korea Nuclear Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 45. South Korea Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

Figure 46. South Korea Nuclear Medicine Sales Value by Application (%), 2023 VS 2030

Figure 47. Southeast Asia Nuclear Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

Figure 49. Southeast Asia Nuclear Medicine Sales Value by Application (%), 2023 VS 2030

Figure 50. India Nuclear Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 51. India Nuclear Medicine Sales Value by Type (%), 2023 VS 2030

Figure 52. India Nuclear Medicine Sales Value by Application (%), 2023 VS 2030

Figure 53. Nuclear Medicine Industrial Chain

Figure 54. Nuclear Medicine Manufacturing Cost Structure

Figure 55. Channels of Distribution (Direct Sales, and Distribution)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions